For the years ended December 31, (In millions, except per share amounts) 2012 2011 2010 Revenues Premiums and fees $ 26,187 $ 18,966 $ 18,274 Net investment income 1,144 1,146 1,105 Mail order pharmacy revenues 1,623 1,447 1,420 Other revenues 121 244 254 Realized investment gains (losses): Other-than-temporary impairments on fixed maturities, net (11) (26) (1) Other realized investment gains 55 88 76 Total realized investment gains 44 62 75 TOTAL REVENUES 29,119 21,865 21,128 Benefits and Expenses Global Health Care medical claims expense 14,228 9,125 9,222 Other benefit expenses 3,672 3,365 3,011 Mail order pharmacy cost of goods sold 1,328 1,203 1,169 GMIB fair value (gain) loss (41) 234 55 Other operating expenses 7,455 6,062 5,869 TOTAL BENEFITS AND EXPENSES 26,642 19,989 19,326 Income before Income Taxes 2,477 1,876 1,802 Income taxes: Current 719 398 331 Deferred 134 217 188 TOTAL TAXES 853 615 519 Net Income 1,624 1,261 1,283 Less: Net Income Attributable to Redeemable Noncontrolling Interest 1 – – Less: Net Income Attributable to Other Noncontrolling Interest – 1 4 SHAREHOLDERS’ NET INCOME $ 1,623 $ 1,260 $ 1,279 Shareholders’ Net Income Per Share: Basic $ 5.70 $ 4.65 $ 4.69 Diluted $ 5.61 $ 4.59 $ 4.65 Dividends Declared Per Share $ 0.04 $ 0.04 $ 0.04 The accompanying Notes to the Consolidated Financial Statements are an integral part of these statements. Financial Statements and Supplementary Data ITEM 8 Cigna Corporation Consolidated Statements of Income 64 CIGNA CORPORATION -  2012 Form  10-K PART II ITEM 8 Financial Statements and Supplementary Data